The customer alleged erroneous results for 1 patient tested for d bili direct bilirubin (d bili) on a cobas 6000 c (501) module.One patient sample was being tested for multiple chemistry tests and total psa.The total psa test was processed first and then the sample was sent to the c501 module for the other tests.When the tests were completed and were sent to the host, the tech noticed that the d bili result in the laboratory information system (lis) was 5.22 mg/dl.The tech did not accept this result and reviewed what the c501 module tested originally.The initial d bili result was 0.20 mg/dl with a data flag and the sample repeated with the same result.The result of 0.20 mg/dl with a data flag was believed to be the correct result and was reported outside of the laboratory.The result of 5.22 mg/dl could not be located in the data review screen but, according to the log from the lis, this result was produced by the c501 module.Attempts were made to determine when this result was produced, however, due to the customer¿s settings, this could not be confirmed.The result of 5.22 mg/dl could have been overwritten by the next result for d bili.Another potential explanation for the 5.22 mg/dl result was that the customer used an unspun whole blood sample that was tested for d bili, however, the customer states this did not occur.No adverse event occurred.The d bili reagent lot number was 21901301 with an expiration date of 09/30/2018.
|